Utama › Kanser Payudara › New York › Buffalo
Kajian klinikal Kanser Payudara di Buffalo, NY
16 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Buffalo (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
Mengambil pesertaSukarelawan sihat dialu-alukan
- Roswell Park Cancer Institute, Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- Roswell Park Cancer Institute IDS, Buffalo
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Mengambil pesertaFasa 2
- Roswell Park Comprehensive Cancer Center, Buffalo
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Mengambil pesertaFasa 2
- Roswell Park Comprehensive Cancer Center, Buffalo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- Roswell Park Cancer Institute, Buffalo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
Mengambil peserta
- Roswell Park Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- Roswell Park Cancer Institute, Buffalo
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- Roswell Park Cancer Institute, Buffalo
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Mengambil pesertaFasa 1/2
- Roswell Park Cancer Institute, Buffalo
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Mengambil peserta
- Buffalo General Medical Center, Buffalo
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Mengambil peserta
- Roswell Park Comprehensive Cancer Center, Buffalo
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
Mengambil peserta
- Roswell Park Cancer Institute, Buffalo
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Mengambil pesertaKajian pemerhatian
- Roswell Park Cancer Institute, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Buffalo
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- Roswell Park Cancer Institute, Buffalo
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Buffalo
- Kanser Paru-paru Bukan Sel Kecil19 kajian
- Kanser (semua jenis)19 kajian
- Leukemia Mieloid Akut19 kajian
- Kanser Paru-paru16 kajian
- Kanser Ovari13 kajian
- Kanser Metastatik11 kajian
- Kanser Prostat11 kajian
- Melanoma10 kajian
- Mieloma Pelbagai10 kajian
- Obesiti9 kajian
- Limfoma Burkitt8 kajian
- Sindrom Mielodisplastik8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.